Organogenesis Holdings Inc Class A (ORGO)
R&D Expense Growth
20.68%
Quarterly · Period ending:
ORGO R&D Expense Growth
Latest reported20.68%period ending
Latest reported20.68%period ending
ORGO Quarterly R&D Growth (QoQ) (0.00% → 20.68%)
Latest values, visible window
High-resolution chart · PNG
ORGO r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 20.6847% | |
| 47.3945% | |
| -22.1995% | |
| 27.1861% | |
| -2.3026% | |
| -7.719% | |
| 11.4656% | |
| -33.637% | |
| 21.6784% | |
| 8.836% | |
| 12.4164% | |
| -4.2787% | |
| -2.3567% | |
| -1.6937% | |
| 19.0078% | |
| -6.1734% | |
| 18.8424% | |
| 3.9588% | |
| -7.7404% | |
| 22.3087% | |
| 17.8934% | |
| -1.4288% | |
| 69.8301% | |
| -20.5441% | |
| -13.7153% | |
| 48.6264% | |
| -7.2375% | |
| 1.5528% | |
| 14.6247% | |
| 9.0586% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |